SUBSTANTIAL VARIATION IN THE PRICES OF DRUGS USED IN COST-EFFECTIVENESS ANALYSES OF NOVEL ORAL ANTI-COAGULANTS

被引：0
作者：
Sacks, Chana A. [1 ]
Kesselheim, Aaron [1 ]
Fralick, Michael [1 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S323 / S323
页数：1
相关论文
共 50 条
  • [21] An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
    Li, Nannan
    Cornelissen, Dennis
    Silverman, Stuart
    Pinto, Daniel
    Si, Lei
    Kremer, Ingrid
    Bours, Sandrine
    de Bot, Robin
    Boonen, Annelies
    Evers, Silvia
    van den Bergh, Joop
    Reginster, Jean-Yves
    Hiligsmann, Mickael
    PHARMACOECONOMICS, 2021, 39 (02) : 181 - 209
  • [22] A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis
    Hiligsmann, Mickael
    Evers, Silvia M.
    Ben Sedrine, Wafa
    Kanis, John A.
    Ramaekers, Bram
    Reginster, Jean-Yves
    Silverman, Stuart
    Wyers, Caroline E.
    Boonen, Annelies
    PHARMACOECONOMICS, 2015, 33 (03) : 205 - 224
  • [23] Associations Between Industry Sponsorship and Results of Cost-effectiveness Analyses of Drugs Used in Breast Cancer Treatment
    Lane, Jordan D.
    Friedberg, Mark W.
    Bennett, Charles L.
    JAMA ONCOLOGY, 2016, 2 (02) : 274 - 276
  • [24] Relationship of Industry Sponsorship to Results of Cost-effectiveness Analyses of Drugs Used in Breast Cancer Treatment Reply
    Bennett, Charles L.
    Lane, Jordan D.
    JAMA ONCOLOGY, 2016, 2 (04) : 549 - 549
  • [25] Cost-effectiveness analyses of osteoarthritis oral therapies: A systematic review
    Wielage R.C.
    Myers J.A.
    Klein R.W.
    Happich M.
    Applied Health Economics and Health Policy, 2013, 11 (6) : 593 - 618
  • [26] COST-EFFECTIVENESS OF NOVEL DRUGS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
    Silbernagel, Gunther
    Bilger, Marcel
    ATHEROSCLEROSIS, 2024, 395
  • [27] Systematic review of cost-effectiveness analyses of novel oral anticoagulants for stroke prevention in atrial fibrillation
    Ferreira, Joao
    Mirco, Ana
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2015, 34 (03) : 179 - 191
  • [28] KEY DRIVERS OF COST-EFFECTIVENESS OF ANTI-CANCER DRUGS
    Hoyle, M.
    ANNALS OF ONCOLOGY, 2014, 25
  • [29] A REVIEW OF COST-EFFECTIVENESS STUDIES FOR ANTI-EPILEPTIC DRUGS
    Khan, N.
    Shah, D.
    Wang, Z.
    Tongbram, V
    Verdian, L.
    VALUE IN HEALTH, 2012, 15 (04) : A145 - A145
  • [30] Building a short-term cost-effectiveness model for oral anti-diabetic drugs in the UK
    Annemans, L
    Siddons, P
    Hood, SC
    DIABETOLOGIA, 1997, 40 : 2608 - 2608
12345